ET
ABMD

Equitable Trust’s Abiomed Inc ABMD Stock Holding History

Equitable Trust’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,073
Closed -$342K – 381
2021
Q1 		$342K Sell
1,073
-1,327
-55% -$425K 0.03% 287
2020
Q4 		$778K Hold
2,400
– – 0.06% 207
2020
Q3 		$665K Hold
2,400
– – 0.06% 206
2020
Q2 		$580K Sell
2,400
-1,221
-34% -$245K 0.05% 205
2020
Q1 		$526K Buy
3,621
+1,100
+44% +$183K 0.06% 201
2019
Q4 		$430K Buy
2,521
+35
+1% +$6.49K 0.04% 212
2019
Q3 		$442K Buy
2,486
+36
+1% +$7.78K 0.05% 206
2019
Q2 		$638K Hold
2,450
– – 0.07% 181
2019
Q1 		$700K Hold
2,450
– – 0.08% 171
2018
Q4 		$796K Buy
2,450
+50
+2% +$17.4K 0.11% 160
2018
Q3 		$1.08M Buy
+2,400
New +$946K 0.13% 149

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Equitable Trust's ABMD Position: Q2 2021 in Review

Equitable Trust sold out of Abiomed Inc (ABMD) in Q2 2021, closing a stake of 1,073 shares — an estimated $342K sold.

Equitable Trust first reported a position in ABMD in Q3 2018 and held it in 11 quarters. The position peaked at $1.08M in Q3 2018. 474 funds tracked by Wall St. Rank hold ABMD as of Q2 2021.

  • Equitable Trust reported no remaining Abiomed Inc position as of Q2 2021 after selling out during the quarter.
  • Equitable Trust sold 1,073 Abiomed Inc shares in Q2 2021, an estimated $342K.
  • Equitable Trust first reported a position in Abiomed Inc in Q3 2018 and held it in 11 quarters.
  • Equitable Trust's Abiomed Inc position peaked at $1.08M in Q3 2018.
  • 474 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2021.

Based on Equitable Trust's 13F filing for Q2 2021, filed 3 Aug 2021.